Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/31/2001 | WO2001038550A2 Methods for altering the expression of hyphal-specific genes |
05/31/2001 | WO2001038549A1 Compositions and methods utilizing sequences for controlling nucleic acid expression in yeast |
05/31/2001 | WO2001038548A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
05/31/2001 | WO2001038547A2 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
05/31/2001 | WO2001038546A1 Improving dideoxynucleotide-triphosphate utilization by the hyper-thermophilic dna polymerase from the archaeon pyrococcus furiosus |
05/31/2001 | WO2001038545A1 A novel polypeptide, a human acetyl galactosyl transferase 45 and the polynucleotide encoding the polypeptide |
05/31/2001 | WO2001038544A1 Method for purifying proteins |
05/31/2001 | WO2001038543A1 A NOVEL POLYPEPTIDE, A HUMAN ACYL CoA REDUCTASE 55 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE |
05/31/2001 | WO2001038542A1 Ilk-2, an integtrin-linked kinase |
05/31/2001 | WO2001038541A1 Moss genes from physcomitrella patents encoding proteins involved in the synthesis of polyunsaturated fatty acids and lipids |
05/31/2001 | WO2001038538A1 Polymerase compositions and methods of use thereof |
05/31/2001 | WO2001038537A1 Method of constructing cell-fusion type morbillivirus mutant |
05/31/2001 | WO2001038536A1 GlmU POLYPEPTIDE AND DNA ENCODING THE POLYPEPTIDE |
05/31/2001 | WO2001038535A1 Chimeric gene enabling expression of the gene or cdna of type i insulin-like growth factor (igf-i) in the pancreas and utilization thereof in genic therapy of diabetes mellitus |
05/31/2001 | WO2001038534A2 Human serpin |
05/31/2001 | WO2001038533A2 G protein-coupled receptor-like receptors and modulators thereof |
05/31/2001 | WO2001038532A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
05/31/2001 | WO2001038531A1 Human nucleoprotein having www domain and polynucleotide encoding the same |
05/31/2001 | WO2001038530A1 Use of disease-associated gene |
05/31/2001 | WO2001038529A1 Novel polypeptide, novel dna, novel anitbody and novel transgenic animal |
05/31/2001 | WO2001038528A1 Cell proliferation inhibitory protein, polynucleotide, antisense polynucleotide to the polynucleotide, and cell proliferation inhibitors, cancer diagnostics, cancer remedies and compositions for gene therapy by using the same |
05/31/2001 | WO2001038527A1 Novel protein tab2 |
05/31/2001 | WO2001038526A1 Human tnf receptor |
05/31/2001 | WO2001038525A1 A novel polypeptide, a human fd23 and the polynucleotide encoding the polypeptide |
05/31/2001 | WO2001038524A1 A novel polypeptide, a human s100 calcium binding protein 21 and the polynucleotide encoding the polypeptide |
05/31/2001 | WO2001038523A1 A novel polypeptide, a human deafness-related gene 14 and the polynucleotide encoding the polypeptide |
05/31/2001 | WO2001038522A1 A novel polypeptide, a human histone h2a.21 and the polynucleotide encoding the polypeptide |
05/31/2001 | WO2001038521A1 A novel polypeptide, a human calcium binding protein 42 and the polynucleotide encoding the polypeptide |
05/31/2001 | WO2001038520A1 A novel polypeptide, a human phospholipid bilayer movement-relative protein 36 and the polynucleotide encoding the polypeptide |
05/31/2001 | WO2001038519A1 Novel nucleic acid and polypeptide |
05/31/2001 | WO2001038518A1 Promoter and intron from maize actin depolymerizing factor |
05/31/2001 | WO2001038517A1 Gene expressing protein capable of capturing metal |
05/31/2001 | WO2001038516A1 Method for purifying plasmid dna by anion-exchange chromatography |
05/31/2001 | WO2001038515A1 A method for isolating phenotype switch molecules and phenotype related gene batteries |
05/31/2001 | WO2001038514A2 Methods, media and apparatus for the introduction of molecules into plant cells and bacteria using aerosol beams |
05/31/2001 | WO2001038513A2 Shuffling of agrobacterium and viral genes, plasmids and genomes for improved plant transformation |
05/31/2001 | WO2001038512A2 Enhanced transgene expression by co-expression with a suppressor of post-transcriptional gene silencing (ptgs) |
05/31/2001 | WO2001038511A2 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
05/31/2001 | WO2001038510A2 Integration vectors and method for producing recombinant proteins in fungi |
05/31/2001 | WO2001038509A1 Method for the mutagenesis of nucleotide sequences from plants algae or fungi |
05/31/2001 | WO2001038508A2 Method for carrying out the controlled post-harvest production of proteins in host organisms |
05/31/2001 | WO2001038507A1 Arabidopsis-origin gdp-4-keto-6-deoxy-d-mannose-3,5-epimerase-4-reductase gene |
05/31/2001 | WO2001038504A2 Homologous recombination in plants |
05/31/2001 | WO2001038503A2 Novel human protein kinases and protein kinase-like enzymes |
05/31/2001 | WO2001038502A2 Oleoyl-acyl-carrier-protein thioesterases in plants |
05/31/2001 | WO2001038500A2 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same |
05/31/2001 | WO2001038499A1 Membrane virus host range mutations and their uses as vaccine substrates |
05/31/2001 | WO2001038490A2 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
05/31/2001 | WO2001038488A2 Gene expression by positive feedback activation of a cell type-specific promoter |
05/31/2001 | WO2001038486A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
05/31/2001 | WO2001038485A2 NEMATODE-UPREGULATED PEROXIDASE GENE AND PROMOTER FROM NEMATODE-RESISTANT MAIZE LINE Mp307 |
05/31/2001 | WO2001038484A2 Moss genes from physcomitrella patens coding proteins involved in the synthesis of polyunsaturated fatty acids and lipids |
05/31/2001 | WO2001038482A1 Hybridization device, case, support, and label agent |
05/31/2001 | WO2001038393A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
05/31/2001 | WO2001038392A1 Novel transcription factor and dna thereof |
05/31/2001 | WO2001038391A1 A novel polypeptide - calcium-binding/actin cross-linking protein and a polynucleotide sequence encoding the same |
05/31/2001 | WO2001038390A1 A novel polypeptide - human snare protein 25 and a polynucleotide encoding the same |
05/31/2001 | WO2001038389A1 A new polypeptide-ribosomal protein l14.22 and the polynucleotide encoding it |
05/31/2001 | WO2001038388A1 A novel polypeptide - human branched chain transacylase 31 and a polynucleotide encoding the same |
05/31/2001 | WO2001038387A1 A novel polypeptide - human cytochrome oxidase-related protein 37 and a polynucleotide encoding the same |
05/31/2001 | WO2001038386A1 A novel polypeptide - human sr splicing factor 52 and a polynucleotide encoding the same |
05/31/2001 | WO2001038385A1 A new polypeptide-human phosphatase 79 and the polynucleotide encoding it |
05/31/2001 | WO2001038384A1 A novel polypeptide - human type v14 adenylyl cyclase and a polynucleotide encoding the same |
05/31/2001 | WO2001038383A1 A novel polypeptide - human ubiquitin carboxy-terminal hydrolase (28) and a polynucleotide encoding the same |
05/31/2001 | WO2001038382A1 A novel polypeptide - human actin-binding protein 54 and a polynucleotide encoding the same |
05/31/2001 | WO2001038381A1 A NOVEL POLYPEPTIDE - HUMAN cGMP-INHIBITED PHOSPHODIESTERASE 17 AND A POLYNUCLEOTIDE ENCODING THE SAME |
05/31/2001 | WO2001038380A1 A novel polypeptide - human cell nucleus regulatory protein 56 and a polynucleotide encoding the same |
05/31/2001 | WO2001038379A1 A new polypeptide-human ribosomal protein l23 and the polynucleotide encoding it |
05/31/2001 | WO2001038378A1 A new polypeptide-zinc finger protein 69 and the polynucleotide encoding it |
05/31/2001 | WO2001038377A1 A novel polypeptide - human bromodomain-containing protein 95 and a polynucleotide encoding the same |
05/31/2001 | WO2001038376A1 A new polypeptide-zinc finger protein 46 and the polynucleotide encoding it |
05/31/2001 | WO2001038375A1 A new polypeptide-zinc finger protein 58 and the polynucleotide encoding it |
05/31/2001 | WO2001038374A1 Tumour suppressor factor |
05/31/2001 | WO2001038362A2 Production of vaccines |
05/31/2001 | WO2001038361A1 Modified adenovirus fibre and uses |
05/31/2001 | WO2001038360A2 Novel hcv non-structural polypeptide |
05/31/2001 | WO2001038358A2 Hbv/hcv virus-like particle |
05/31/2001 | WO2001038350A2 85kDa NEISSERIAL ANTIGEN |
05/31/2001 | WO2001038348A2 G-protein coupled receptor htogh35 |
05/31/2001 | WO2001038346A2 Short peptides to target epithelial cells |
05/31/2001 | WO2001038335A1 Phosphorus-containing dendrimers as transfection agents |
05/31/2001 | WO2001037987A1 A method for selective removal of a substance from samples containing compounds having nucleic acid structure |
05/31/2001 | WO2001037958A2 Electrodeless dielectrophoresis for polarizable particles |
05/31/2001 | WO2001037881A2 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
05/31/2001 | WO2001037861A1 A conjugate of a collagen ii-binding fragment and an arthritis-affecting pharmaceutical substance |
05/31/2001 | WO2001037859A2 Pharmaceutical compositions containing compounds which increase or decrease tmtnf levels |
05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
05/31/2001 | WO2001037852A2 Methods of inhibiting atrophy or promoting hypertrophy |
05/31/2001 | WO2001037821A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
05/31/2001 | WO2001037809A1 Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
05/31/2001 | WO2001037807A1 Modular targeted liposomal delivery system |
05/31/2001 | WO2001037779A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
05/31/2001 | WO2001037665A1 Compositions and methods for drug delivery using amphiphile binding molecules |
05/31/2001 | WO2001037654A2 METHOD OF EXPRESSING dsRNA IN PLANTS TO INHIBIT INSECT PESTS |
05/31/2001 | WO2001037645A1 Transformation of ricinus communis the castor plant |
05/31/2001 | WO2001037644A1 Method for lowering pollen fertility by using tapetal layer-specific zinc finger transcriptional factor gene |
05/31/2001 | WO2001037643A1 Method for lowering pollen fertility by using pollen-specific zinc finger transcriptional factor genes |
05/31/2001 | WO2001016327A3 Method for producing a channel-forming protein |
05/31/2001 | WO2001012782A3 Transgenically modified plant cells and plants having modified gbssi- and be-protein activity |
05/31/2001 | WO2001011030A3 Method and means for inducing cell-multiplication of non-active cells |